Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab

BACKGROUND: It remains unclear why radiation clinically provides a synergistic effect when combined with immune checkpoint inhibitors such as nivolumab. The purpose of our study was to retrospectively evaluate whether the therapeutic efficacy of nivolumab is improved as a result of a history of radi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Ou, Kaira, Kyoichi, Hashimoto, Kosuke, Mouri, Atsuto, Miura, Yu, Shiono, Ayako, Nishihara, Fuyumi, Murayama, Yoshitake, Noda, Shin‐ei, Kato, Shingo, Kobayashi, Kunihiko, Kagamu, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449241/
https://www.ncbi.nlm.nih.gov/pubmed/30888716
http://dx.doi.org/10.1111/1759-7714.13044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449241/
https://www.ncbi.nlm.nih.gov/pubmed/30888716
http://dx.doi.org/10.1111/1759-7714.13044

Ejemplares similares